Skip to main content
Log in

Postoperative Levonorgestrel-Releasing Intrauterine System Insertion After Gonadotropin-Releasing Hormone Agonist Treatment for Preventing Endometriotic Cyst Recurrence: A Prospective Observational Study

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Objective

The aim of this study was to evaluate the effectiveness of postoperative levonorgestrel-releasing intrauterine system (LNG-IUS) insertion after gonadotropin-releasing hormone agonist (GnRH-a) treatment for preventing endometriotic cyst recurrence.

Study Design

The LNG-IUS was applied to 28 women who had undergone surgery for endometriosis followed by 6 cycles of GnRH-a treatment. Clinical characteristics, endometriosis recurrence, and adverse effects were analyzed. Student t test was performed for analysis.

Results

Before surgery, 20 (71.4%) patients had dysmenorrhea, and the mean pain score (visual analog scale [VAS]) was 4.26. The numbers of women diagnosed with stage III endometriosis and stage IV endometriosis were 15 (53.6%) and 13 (46.4%), respectively, according to the revised American Fertility Society scoring system. The mean cancer antigen 125 levels and VAS scores were significantly lower after treatment than before treatment (11.61 vs 75.66 U/mL, P <.0001 and 0.50 vs 4.26 U/mL, P <.0001, respectively). Of the 28 patients, 13 (46.4%) simultaneously had adenomyosis, and 2 (7.1%) underwent LNG-IUS removal because of unresolved vaginal bleeding and dysmenorrhea. Recurrence was noted in 2 (7.1%) women.

Conclusion

Postoperative LNG-IUS insertion after GnRH-a treatment is an effective approach for preventing endometriotic cyst recurrence, especially in women who do not desire to conceive.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fauconnier A, Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update. 2005;11(6):595–606.

    CAS  Google Scholar 

  2. Winkel CA. Evaluation and management of women with endometriosis. Obstet Gynecol. 2003;102(2):397–408.

    Google Scholar 

  3. Garry R. The effectiveness of laparoscopic excision of endometriosis. Curr Opin Obstet Gynecol. 2004;16(4):299–303.

    PubMed  Google Scholar 

  4. Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update. 2009;15(4):441–461.

    PubMed  Google Scholar 

  5. Bayoglu Tekin Y, Dilbaz B, Altinbas SK, Dilbaz S. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. Fertil Steril. 2011;95(2):492–496.

    CAS  PubMed  Google Scholar 

  6. Takamura M, Koga K, Osuga Y, et al. Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision. Hum Reprod. 2009;24(12):3042–3048.

    CAS  PubMed  Google Scholar 

  7. Loverro G, Carriero C, Rossi AC, Putignano G, Nicolardi V, Selvaggi L. A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III–IV endometriosis. Eur J Obstet Gynecol Reprod Biol. 2008;136(2):194–198.

    CAS  PubMed  Google Scholar 

  8. Sesti F, Pietropolli A, Capozzolo T, et al. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III–IV. A randomized comparative trial. Fertil Steril. 2007;88(6):1541–1547.

    PubMed  Google Scholar 

  9. Lee DY, Bae DS, Yoon BK, Choi D. Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence. Hum Reprod. 2010;25(12):3050–3054.

    CAS  PubMed  Google Scholar 

  10. Park HJ, Koo YA, Yoon BK, Choi D. Postoperative long-term maintenance therapy with oral contraceptives after gonadotropin-releasing hormone analog treatment in women with ovarian endo-metrioma. J Minim Invasive Gynecol. 2009;16(1):34–39.

    PubMed  Google Scholar 

  11. Lee JY, Park SM, Ko YJ, Song YS. Necessity of education for oral contraceptive use in Korea: results from the fourth Korean national health and nutrition examination survey 2007–2009. Gynecol Obstet Invest. 2013;76(1):44–50.

    PubMed  Google Scholar 

  12. Wiebe ER, Henderson A, Choi J, Trouton K. Ethnic Korean women’s perceptions about birth control. Contraception. 2006;73(6):623–627.

    PubMed  Google Scholar 

  13. Brown J, Farquhar C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2014;10(3):CD009590.

    Google Scholar 

  14. Morelli M, Sacchinelli A, Venturella R, Mocciaro R, Zullo F. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients. J Obstet Gynaecol Res. 2013;39(5):985–990.

    PubMed  Google Scholar 

  15. Cho S, Jung JA, Lee Y, et al. Postoperative levonorgestrel-releasing intrauterine system versus oral contraceptives after gonadotropin-releasing hormone agonist treatment for preventing endometrioma recurrence. Acta Obstet Gynecol Scand. 2014;93(1):38–44.

    CAS  PubMed  Google Scholar 

  16. Exacoustos C, Zupi E, Carusotti C, et al. Staging of pelvic endometriosis: role of sonographic appearance in determining extension of disease and modulating surgical approach. J Am Assoc Gynecol Laparosc. 2003;10(3):378–382.

    PubMed  Google Scholar 

  17. Callen P. Ultrasonography in Obstetrics and Gynecology. 5th edition; Philadelphia, PA: Saunders, 2008:928.

    Google Scholar 

  18. Koga K, Takamura M, Fujii T, Osuga Y. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil Steril. 2015;104(4):793–801.

    PubMed  Google Scholar 

  19. Vignali M, Bianchi S, Candiani M, Spadaccini G, Oggioni G, Busacca M. Surgical treatment of deep endometriosis and risk of recurrence. J Minim Invasive Gynecol. 2005;12(6):508–513.

    PubMed  Google Scholar 

  20. Jinushi M, Arakawa A, Matsumoto T, et al. Histopathologic analysis of intestinal endometriosis after laparoscopic low anterior resection. J Minim Invasive Gynecol. 2011;18(1):48–53.

    PubMed  Google Scholar 

  21. Bulletti C, DeZiegler D, Stefanetti M, Cincinelli E, Pelosi E, Flamigni C. Endometriosis: absence of recurrence in patients after endometrial ablation. Hum Reprod. 2001;16(12):2676–2679.

    CAS  PubMed  Google Scholar 

  22. Goumenou AG, Chow C, Taylor A, Magos A. Endometriosis arising during estrogen and testosterone treatment 17 years after abdominal hysterectomy: a case report. Maturitas. 2003;46(3):239–241.

    CAS  PubMed  Google Scholar 

  23. Vercellini P, Somigliana E, Vigano P, Abbiati A, Barbara G, Fedele L. ‘Blood On The Tracks’ from corpora lutea to endometriomas. BJOG. 2009;116(3):366–371.

    CAS  PubMed  Google Scholar 

  24. DiVasta AD, Feldman HA, Sadler Gallagher J, et al. Hormonal add-back therapy for females treated with gonadotropin-releasing hormone agonist for endometriosis: a randomized controlled trial. Obstet Gynecol. 2015;126(3):617–627.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Vercellini P, Somigliana E, Daguati R, Vigano P, Meroni F, Crosignani PG. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol. 2008;198(5):504.e501–504.e505.

    Google Scholar 

  26. Ouchi N, Akira S, Mine K, Ichikawa M, Takeshita T. Recurrence of ovarian endometrioma after laparoscopic excision: Risk factors and prevention. J Obstet Gynaecol Res. 2014;40(1):230–236.

    PubMed  Google Scholar 

  27. Perello MF, Martinez-Zamora MA, Torres X, Munros J, Balasch Cortina J, Carmona F. Endometriotic pain is associated with adenomyosis but not with the compartments affected by deep infiltrating endometriosis. Gynecol Obstet Invest. 2017;82(3):240–246.

    PubMed  Google Scholar 

  28. Petta CA, Ferriani RA, Abrao MS, et al. A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system. Eur J Obstet Gynecol Reprod Biol. 2009;143(2):128–129.

    CAS  PubMed  Google Scholar 

  29. Kriplani A, Singh BM, Lal S, Agarwal N. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia. Int J Gynaecol Obstet. 2007;97(3):190–194.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seok Kyo Seo MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, M.K., Chon, S.J., Lee, J.H. et al. Postoperative Levonorgestrel-Releasing Intrauterine System Insertion After Gonadotropin-Releasing Hormone Agonist Treatment for Preventing Endometriotic Cyst Recurrence: A Prospective Observational Study. Reprod. Sci. 25, 39–43 (2018). https://doi.org/10.1177/1933719117718274

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719117718274

Keywords

Navigation